Amgen CEO’s pay declines 29%
From Times Wire Services
Amgen Inc. Chief Executive Kevin Sharer’s compensation fell sharply to $13.2 million in 2007, a year when shares in the world’s largest biotechnology company plunged amid government warnings about its leading drugs.
Sharer’s pay dropped nearly 29% from his total 2006 compensation of $18.6 million, according to figures in an Amgen filing with the Securities and Exchange Commission.
